Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma

Hanna et al. (Sun,) studied this question.

www.synapsesocial.com/papers/68e66854b6db6435875f4b9a — DOI: https://doi.org/10.1158/1078-0432.ccr-24-0590

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck· 2024 · 24 citations
2. <i>Paired Box 5</i> Methylation Detection by Droplet Digital PCR for Ultra-Sensitive Deep Surgical Margins Analysis of Head and Neck Squamous Cell Carcinoma· 2015 · 26 citations
3. Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma· 2022 · 118 citations
4. Abstract 4542: Analytical validation of the SignateraTM RUO assay, a highly sensitive patient-specific multiplex PCR NGS-based noninvasive cancer recurrence detection and therapy monitoring assay· 2018 · 15 citations
5. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study· 2017 · 110 citations